Antipas, Amy
8  results:
Search for persons X
?
1

Patient Acceptability and Preferences for Solid Oral Dosage..:

Hauber, Brett ; Hand, Mark ; Hancock, Bruno...
Patient Preference and Adherence.  18 (2024)  - p. 1281-1297 , 2024
 
?
2

Development and evaluation of novel solid nanodispersion sy..:

Nkansah, Paul ; Antipas, Amy ; Lu, Ying...
Journal of Controlled Release.  169 (2013)  1-2 - p. 150-161 , 2013
 
?
3

Structure–activity relationships and hepatic safety risks o..:

Antipas, Amy S. ; Blumberg, Laura C. ; Brissette, William H....
Bioorganic & Medicinal Chemistry Letters.  20 (2010)  14 - p. 4069-4072 , 2010
 
?
4

The identification of orally bioavailable thrombopoietin ag..:

Munchhof, Michael J. ; Antipas, Amy S. ; Blumberg, Laura C....
Bioorganic & Medicinal Chemistry Letters.  19 (2009)  5 - p. 1428-1430 , 2009
 
?
5

Potent, selective spiropyrrolidine pyrimidinetrione inhibit..:

Freeman-Cook, Kevin D. ; Reiter, Lawrence A. ; Noe, Mark C....
Bioorganic & Medicinal Chemistry Letters.  17 (2007)  23 - p. 6529-6534 , 2007
 
?
6

Pyrimidine benzamide-based thrombopoietin receptor agonists:

Reiter, Lawrence A. ; Subramanyam, Chakrapani ; Mangual, Emilio J....
Bioorganic & Medicinal Chemistry Letters.  17 (2007)  19 - p. 5447-5454 , 2007
 
?
 
1-8